0001415889-23-013046.txt : 20230906 0001415889-23-013046.hdr.sgml : 20230906 20230906190740 ACCESSION NUMBER: 0001415889-23-013046 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230715 FILED AS OF DATE: 20230906 DATE AS OF CHANGE: 20230906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moat Ross CENTRAL INDEX KEY: 0001857177 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38492 FILM NUMBER: 231240629 MAIL ADDRESS: STREET 1: C/O KINIKSA PHARMACEUTICALS LTD. STREET 2: CLARENDON HOUSE, 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd. CENTRAL INDEX KEY: 0001730430 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 BUSINESS PHONE: 7814399100 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 4 1 form4-09062023_110933.xml X0508 4 2023-07-15 0001730430 Kiniksa Pharmaceuticals, Ltd. KNSA 0001857177 Moat Ross C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11 BERMUDA false true false false CHIEF COMMERCIAL OFFICER 0 Class A Common Share 2023-07-15 4 A 0 292 12.35 A 12845 D Class A Common Share 2023-09-01 4 M 0 2477 A 15322 D Class A Common Share 2023-09-01 4 F 0 1353 17.76 D 13969 D Class A Common Share 2023-09-02 4 M 0 994 A 14963 D Class A Common Share 2023-09-02 4 F 0 543 17.76 D 14420 D Restricted Share Unit 2023-09-01 4 M 0 2477 0 D Class A Common Share 2477 7431 D Restricted Share Unit 2023-09-01 4 A 0 6445 0 A Class A Common Share 6445 6445 D Share Option 17.76 2023-09-01 4 A 0 38668 0 A 2033-08-31 Class A Common Share 38668 38668 D Restricted Share Unit 2023-09-02 4 M 0 994 0 D Class A Common Share 994 1988 D The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of January 16, 2023 to July 15, 2023. The acquisition of such shares was exempt pursuant to Rule 16b-3(c). Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 1, 2022. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 1, 2023. The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2023. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 2, 2021. /s/ Madelyn Zeylikman, Attorney-in-Fact 2023-09-06